drugset / Trial / NCT04522297
Nor-epinephrine Versus Midodrine/Octreotide in Patients With Hepatorenal Syndrome
RandomizedParallel-groupOpen-labelTreatment
Summary
Hepatorenal syndrome is a functional renal impairment occurring in cirrhotic patients . It develops secondary to splanchnic arterial vasodilatation which decreases the effective blood volume, activate the renin-angiotensin-aldosterone system, and stimulate of sympathetic nervous system.This study aims to compare the efficacy of nor-epinephrine versus midodrine/ octreotide, together with intravenous albumin on renal functions of patients with hepatorenal acute kidney injury.
Timeline
- Start
- 2018-04-15
- Primary completion
- 2020-01-23
- Completion
- 2020-01-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Midodrine | Small molecule | — | Oral |
| Comparator | Norepinephrine | Other / unclassified | — | Intravenous |
| Subject | Octreotide | Peptide | — | Subcutaneous |